IP Library Granted Patent US 10,656,056
Granted Patent B2
US 10,656,056 · App. 15/591,838 · Granted May 19, 2020

Fixative and staining solutions

Inventors: Daniel Lapen (Lancaster, MA); Kerri Horton (Boston, MA)
Assignee: Roche Diagnostics Hematology, Inc.
G01N1/30Y10T436/10Y10T436/101666Y10T436/108331Y10T436/25
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,656,056
App. No.
15/591,838
Granted
May 19, 2020
Kind
B2
Abstract

The formulations, systems, and methods disclosed herein permit automated preparation of specimens (e.g., biological specimens) for examination. The disclosed formulations, systems, and methods provide fast, efficient, and highly uniform specimen processing using minimal quantities of fluids. The methods include at least a fixing phase for fixing a specimen to a substrate such as a microscope slide, a staining phase for staining the specimen, and a rinsing phase for rinsing the specimen. One or more of the fixing, staining, and rinsing phases include one or more agitation phases for distributing reagents evenly and uniformly across the specimen. The systems can be implemented as a standalone device or as a component in a larger system for preparing and examining specimens.

Claims (14)

1. A cytological fixative solution, consisting of

a single cytological dye in an amount of from 0.5 g/L to 5.0 g/L;

0.5 mL/L to 5.0 mL/L polysorbate 20;

5 mL/L to 50 mL/L ethylene glycol;

0.10 g/L to 10 g/L HEPES sodium salt; and

alcohol.

2. The cytological fixative solution of claim 1 , wherein the polysorbate 20 is present in an amount of from 0.05% to 0.3% by volume.

3. The cytological fixative solution of claim 1 , wherein a 1:10 dilution of the solution in water has a pH of from 6 to 8 and HEPES is present in an amount of from 0.5 mM to 10 mM.

4. The cytological fixative solution of claim 1 , wherein a 1:10 dilution of the solution in water has a pH of from 6.7 to 7.3 and HEPES is present in an amount of from 0.5 mM to 10 mM.

5. The cytological fixative solution of claim 1 , wherein a 1:1000 dilution of the fixative solution in water has a UV absorbance of from 0.1 to one at a peak wavelength of from 640 to 650 nm.

6. The cytological fixative solution of claim 1 , wherein the cytological dye is methylene blue, eosin, or a fluorescein derivative.

7. The cytological fixative solution of claim 1 , wherein the alcohol is methanol, ethanol, or isopropanol.

8. The cytological fixative solution of claim 1 , wherein the cytological dye is Azure B.

9. The cytological fixative solution of claim 1 , wherein the cytological dye is a thiazine dye.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2017
From: LAPEN, DANIEL; HORTON, KERRI
To: CONSTITUTION MEDICAL, INC.
Reel/Frame 044152/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2017
From: CONSTITUTION MEDICAL, INC.
To: ROCHE DIAGNOSTICS HEMATOLOGY, INC.
Reel/Frame 044152/0359 →
Continuity (6)
Continuation 13795536 · Mar 12, 2013
Continuation 13526164 · Jun 18, 2012
Provisional Application 61498159 · Jun 17, 2011
Provisional Application 61505011 · Jul 6, 2011
Provisional Application 61510180 · Jul 21, 2011
Related Publication 20180113059A1 · Apr 26, 2018